Minerva Neuroscience
Clinical development of treatments for central nervous system disorders.
Launch date
Employees
Market cap
$20.6m
Enterprise valuation
($10m) (Public information from Sep 2024)
Share price
$2.85 NERV
Waltham Massachusetts (HQ)
Authorizing premium user...